Neuralink obtains breakthrough designation from FDA for Blindsight device
The device enables visual perception by processing and transmitting neural signals, even without eyes or an optic nerve.
The device enables visual perception by processing and transmitting neural signals, even without eyes or an optic nerve.
The AI model can accurately predict who is at a high risk of developing sight-threatening diabetic retinopathy up to three years in advance.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Alio starts trial to expand label for remote monitoring device
Firefly and Zeto team up to distribute EEG headset devices
AstraZeneca eyes up transition to eco-friendly inhaler propellant
Apple to add sleep apnoea notification to Series 10 watch